Literature DB >> 17971579

Reducing xerostomia by IMRT: what may, and may not, be achieved.

Avraham Eisbruch.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 17971579     DOI： 10.1200/JCO.2007.13.4874

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  12 in total

Review 1.  Balancing risk and reward in target delineation for highly conformal radiotherapy in head and neck cancer.

Authors:  Avraham Eisbruch; Vincent Gregoire
Journal:  Semin Radiat Oncol       Date:  2009-01       Impact factor: 5.934

2.  Botulinum Toxin Confers Radioprotection in Murine Salivary Glands.

Authors:  Youssef H Zeidan; Nan Xiao; Hongbin Cao; Christina Kong; Quynh-Thu Le; Davud Sirjani
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-12-29       Impact factor: 7.038

3.  Correction of systematic set-up error in breast and head and neck irradiation through a no-action level (NAL) protocol.

Authors:  Eva M Lozano; Luis A Pérez; Javier Torres; Carmen Carrascosa; Miguel Sanz; Fermín Mendicote; Antonio Gil
Journal:  Clin Transl Oncol       Date:  2011-01       Impact factor: 3.405

4.  Functional swallowing outcomes in nasopharyngeal cancer treated with IMRT at 6 to 42 months post-radiotherapy.

Authors:  Margaret Patterson; Rowena Brain; Ronald Chin; David Veivers; Michael Back; Andrew Wignall; Thomas Eade
Journal:  Dysphagia       Date:  2014-08-13       Impact factor: 3.438

5.  Intensity-modulated radiotherapy increases dose to the brachial plexus compared with conventional radiotherapy for head and neck cancer.

Authors:  A M Chen; W H Hall; B-Q Li; M Guiou; C Wright; M Mathai; A Dublin; J A Purdy
Journal:  Br J Radiol       Date:  2010-09-21       Impact factor: 3.039

6.  [Xerostomia. Improved care using a spray with herbal polysaccharides].

Authors:  F Momm; M-B Messmer; S Kirste; G Becker
Journal:  HNO       Date:  2010-07       Impact factor: 1.284

7.  Effectiveness of combined modality radiotherapy of orthotopic human squamous cell carcinomas in Nu/Nu mice using cetuximab, tirapazamine and MnSOD-plasmid liposome gene therapy.

Authors:  Michael W Epperly; Stephen Y Lai; Anthony J Kanai; Neal Mason; Brian Lopresi; Tracey Dixon; Darcy Franicola; Yunyun Niu; William R Wilson; Joel S Greenberger
Journal:  In Vivo       Date:  2010 Jan-Feb       Impact factor: 2.155

8.  Comprehensive IMRT plus weekly cisplatin for advanced head and neck cancer: the University of Wisconsin experience.

Authors:  Anne M Traynor; Gregory M Richards; Gregory K Hartig; Deepak Khuntia; James F Cleary; Peggy A Wiederholt; Søren M Bentzen; Paul M Harari
Journal:  Head Neck       Date:  2010-05       Impact factor: 3.147

9.  Dose-effect relationships for the submandibular salivary glands and implications for their sparing by intensity modulated radiotherapy.

Authors:  Carol-Anne Murdoch-Kinch; Hyugnjin M Kim; Karen A Vineberg; Jonathan A Ship; Avraham Eisbruch
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-03-11       Impact factor: 7.038

10.  Submandibular gland-sparing radiation therapy for locally advanced oropharyngeal squamous cell carcinoma: patterns of failure and xerostomia outcomes.

Authors:  Michael F Gensheimer; Jay J Liao; Adam S Garden; George E Laramore; Upendra Parvathaneni
Journal:  Radiat Oncol       Date:  2014-11-26       Impact factor: 3.481
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.